Organization
Keryx Biopharmaceuticals
2 clinical trials
Clinical trial
A 36-week, Single-Arm, Open-label Study to Evaluate the Safety and Tolerability of Ferric Citrate in Children With Hyperphosphatemia Related to Chronic Kidney DiseaseStatus: Recruiting, Estimated PCD: 2025-01-01
Clinical trial
A 24-Week, Open-Label, Randomized, 2-Arm Study to Evaluate the Safety and Tolerability of KRX-0502 (Ferric Citrate) in Children With Iron Deficiency Anemia Associated With Non-Dialysis Dependent Chronic Kidney DiseaseStatus: Not yet recruiting, Estimated PCD: 2027-01-01